A239 COMBINED CANNABINOID RECEPTOR 1 AND MU-OPIOID RECEPTOR AGONISTS SYNERGISTICALLY INHIBIT VISCERAL PAIN <i>IN VIVO</i> WITHOUT ADVERSE SIDE EFFECTS OR TOLERANCE
Journal of the Canadian Association of Gastroenterology